NextGen Omics 2023 features 4 outstanding programmes, bringing together Europe’s most successful omics research experts under one roof. The series provides an excellent networking platform which consists of key discussion topics in: Next Generation Sequencing & Clinical Diagnostics, Single Cell & Spatial Analysis, Synthetic Biology in Discovery & Therapeutics and Digital PCR & Liquid Biopsies
EBRC is co-hosting three regional workshops to identify stakeholder-driven metrics, metrology, and standards to enhance the performance of engineering biology for commercial and industrial activity, with a focus on the needs of start-ups and small companies that are working to bring a tool or product to market. Highlighted topics include supporting translation and scale-up capabilities, improving reproducibility, and enabling clear regulatory frameworks. The information gathered in these workshops will lay the groundwork to establish necessary metrics and open voluntary standards for engineering biology that enable the rapid growth and success of the bioeconomy.
Hear from and meet with the leading figures in biomarker analysis to explore how companies are innovating in biomarker analysis to accelerate timelines and reduce risk in drug development, with in-depth consideration of the latest multiplexed and cytometry tools impacting biomarker research & validation.
Key Speakers:
Mario Richter – AbbVie Deutschland GmbH & Co. KG
Eike Staub – Merck
Siôn Lewis – UCB BioPharma
Li Chin Wong – Prevail Therapeutics
Priyank Patel – Boehringer Ingelheim
Polina Goihberg – Pfizer
European Center of Sustainable Development in collaboration with Canadian Institute of Technology will organize the 11th ICSD 2023 International Conference on Sustainable Development, with particular focus on Environmental, Economic and Socio-Cultural Sustainability.
The Conference theme : Creating a unified foundation for the Sustainable Development: Research, Practice and Education.
The 11th ICSD 2023 will be an excellent opportunity to share your ideas and research findings relevant to the Sustainability Science, through the European network of academics.
Papers will be published in Open Access EJSD Journal (Web of Science) and Proceedings..
This ambition will proceed in a multidisciplinary way across the various fields and perspectives, through which we can address the fundamental and related questions of Sustainable Development.
Join leaders, experts and researchers at West Coast’s scientific Hub – San Diego, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations in formulation, drug delivery & inhaled science.
Formulation & Delivery US 2023 features 2 outstanding programmes, bringing together key opinion leaders under one roof. The events provide a unique networking platform which consists of vital discussion topics in: Formulation & Drug Delivery and Inhalation & Respiratory Drug Delivery.
Speakers Include:
Arvinder Dhalla (Vice President, Clinical Development, Rani Therapeutics)
Charlie (Xiaolin) Tang (Director in Formulation Development, Regeneron)
Gian Luca Araldi (Founder and Chief Executive Officer, Avanti Biosciences)
Grace Yu (President & Chief Executive Officer, Trilogy Therapeutics)
Stephen Pham (Vice President, Product Development, Avalyn Pharma)
Theresa Scheuble (Head of Enterprise Design & Innovation, Johnson & Johnson)
Discuss the latest strategies to harness the immune system for the development of innovative therapeutics
Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine
Join RNA leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the formulation and delivery of RNA-based therapeutics.
Join oligo leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the oligonucleotides chemistry & therapeutics development.
We are excited to announce that registration for the EBRC 2023 Annual Meeting at Northwestern University on June 5-6, 2023 is now open. Registration is open to all EBRC academic members and their lab members, all employees of Industry Member companies, our government colleagues, and members of EBRC’s Student & Postdoc Association. We are also pleased to welcome all faculty, researchers, and trainees at Northwestern’s Center for Synthetic Biology to register and attend.
The EBRC Annual Meeting provides an opportunity for the engineering biology community to come together to engage on matters important to advancing engineering biology. In addition to inspiring research talks and poster presentations, EBRC’s meeting holds time to consider the larger engineering biology research ecosystem in which we all exist and work together to move the field forward. We invite you to join us to present and discuss your latest research, build relationships with your colleagues in academia, industry, and government, and advance the member-driven work of EBRC. View our draft agenda here. Note that we anticipate running until 5:00 PM on Tuesday, June 5.
Registration:
Please register here by May 3, 2023. To confirm your spot and offset some of the meal costs, there will be a nominal fee ($150 for faculty and $75 for students and postdocs). If this fee is prohibitive for you or your lab members, please email helix@ebrc.org.
Abstract submissions for posters are now being accepted. Abstract submission is separate from registration. Submissions from all attendees are welcome! We encourage you to submit your latest, ongoing work as a mechanism to engage in community dialogue.
IMPORTANT DATES:
April 7: Last day to submit talk abstracts
April 21: Notification of talk selection
May 3: Registration closes*
May 5: Deadline for hotel and travel arrangements by EBRC
May 19: Last day to submit poster abstracts
*registration may still be possible after this date but will incur additional costs
Annual Meeting Venue:
Northwestern University
Norris Center
1999 Campus Dr
Evanston, IL 60208
Meeting Hotel:
EBRC has reserved a block of hotel rooms at the Hilton Garden Inn at 1818 Maple Ave, Evanston, IL 60201 at $179.00 per night (includes breakfast and WiFi). Please indicate on the registration page if you will need hotel accommodations. We will reserve the room in our block. If your travel is not covered by EBRC, you can provide payment at check in. Please contact helix@ebrc.org with any questions rather than contacting the hotel directly.
Travel Support:
We anticipate covering airfare and hotel expenses for:
The meeting will conclude at 5:00PM on Tuesday June 6 and we encourage those receiving travel support to find an evening flight out of Chicago O’Hare if at all possible. We will only cover Tuesday night hotel expenses with prior approval. Please contact helix@ebrc.org if you anticipate needing Tuesday night accommodations. Please also note that travel support does not include the confirmation/meal fee ($150 for faculty and $75 for students and postdocs). Email helix@ebrc.org if this fee is prohibitive. Please see EBRC’s full travel policy here.
We encourage you to make your travel plans early, as we will cap the level of airfare support provided by EBRC. Airfare must be booked by May 5 to be eligible for EBRC support.
Health and Safety:
We are committed to hosting a safe event. We will be closely watching CDC recommendations in addition to all relevant local and state guidelines leading up to the Meeting and make any changes necessary for health and safety.
Gene Therapy Development & Manufacturing 2023 delivers in-depth discussion on optimised process strategies and technologies for the successful technical development and manufacture of advanced gene therapy products.
Bringing together leading omics experts from around the world and comprised of three outstanding programmes, delegates can expect to benefit from critical discussions in the future of Next Generation Sequencing, Multi-omic Single Cell & Spatial Analyses and Genome editing in Drug Discovery and Therapeutic Development.
The 2023 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below are some of the confirmed speakers of NextGen Omics US 2023.
Timothy Dahlem, Director of Systems Biology at Recursion Pharmaceuticals
Kamel Khalili, Laura H. Carnell Professor and Chair Lewis Katz School of Medicine at Temple University
Kalina Hristova, Professor of Materials Science and Engineering Institute for NanoBioTechnology at John Hopkins University
Guo-Cheng Yuan, Professor of Computational Biology at Icahn School of Medicine at Mount Sinai
Tirtha Chakraborty, Chief Scientific Officer at Vor Biopharma
Sandra Smieszek, Head of Genetics at Vanda Pharmaceuticals
An innovative 2 day meeting brings together a panel of over 150 prominent leaders and scientists, exploring Sustainable Chemistry, aiming to innovate processes to improve product performance whilst delivering environmental benefits.
Discuss the latest advancements in innovative approaches to sustainable drug development and manufacturing process.
Engage in scientific discussions paving the way towards sustainable chemical synthesis, analytical chemistry and chemical process development.
Dive into the latest technologies driving down pharma sector emissions by implementing “green-by-design” in early drug development phase pipeline projects.
Gain a comprehensive understanding of the peptides and oligonucleotides sustainability landscape; key sessions include application and technology areas.
Join a series of workshops, roundtables, and panel discussions to collaborate with your peers. 2023 sessions include: Greener Peptides, Green Chemical Synthesis, Chemistry in Water, Green Medicinal Chemistry and Green Manufacturing
Engage with esteemed pharmaceutical & biotech representatives as well as thought-leaders from academic & research institutions onsite and benefit from attending over 60 presentations. We will be welcoming onsite over 300 delegates for two days of cutting-edge scientific sessions and case studies bringing the latest biologics developments to the forefront of research
A two-day event packed with leading speakers, research and cutting-edge presentations on the latest advancements in cancer immunotherapy, with dedicated sessions on different therapeutic modalities as well as case studies on innovative preclinical and translational tools.
Biomarkers 2023, designed to provide forward-looking insights into the latest trends and tools impacting biomarker research, it brings together leading experts from global pharmaceutical organisations, innovative biotech companies and internationally renowned academic institutions working across multiple therapeutic areas and stages of drug development.
It includes over 90 cutting-edge presentations and discussion sessions, 8+ hours of valuable networking sessions and an exhibition hall showcasing 50+ vendor companies.
The EBRC Student and Postdoc Association is hosting a Data and Engineering Biology: Operating at the Technical Interface panel event, where researchers can connect with professionals who operate and lead within ‘data-centric’ bioengineering companies.
Panelists will discuss 1) transitioning from their PhD to industry, 2) details about their current role, and 3) which data-specific skills are valued in their organization. The discussion will also cover how lab automation, data science, or DevOps platforms drive overall biology objectives at their companies. Join us virtually on December 6th, 2022 (2-3pm ET |11-12pm PT) on GatherTown by registering here.
Click here to view our flyer.
Please contact Eric South (esouth@bu.edu) if you have any questions.
Diana Koulechova, Ph.D.
LinkedIn
Diana is a Senior Scientist at Tierra Biosciences, where she works to improve and expand their cell-free protein synthesis platform, affecting their internal slogan of “Proteins for All.” Prior to joining Tierra, she developed processes and methods in biologics downstream development at the immunoncology company Agenus, and also prototyped a continuous processing system for biologics manufacturing at the pharmaceutical company Boehringer Ingelheim. She received her PhD in Molecular and Cell Biology from University of California, Berkeley and has been in a variety of biochemistry fields ranging from homing endonucleases, protein folding, and somatosensation in C. elegans.
Ben Gordon, Ph.D.
LinkedIn
Ben is a Senior Director of Research at Asimov Inc. and a Director at the MIT / Broad Synthetic Biology Foundry. He has extensive experience in both managing and leading teams in computer-aided synthetic biology. Ben received a Ph.D. in Computational Biophysical Chemistry from Caltech, where he conducted work on computational protein design and engineering. He later became a Postdoctoral Associate at the Whitehead Institute and then a Principal Scientist and Strategic Collaborations Manager at Agilent Technologies. Ben is also a Program Manager at BioMADE – a Bioindustrial Manufacturing Innovation Institute.
Naomi Handly, Ph.D.
LinkedIn
Naomi is a quantitative cell biologist by training. At Octant, she’s had several roles including recruiting, establishing the OA program, building Octant HQ, demonstrating Octant’s multiplexed platform technology, building cell engineering, and more. Naomi received her PhD from the University of California, San Diego under Roy Wollman quantifying how cells communicate with one another to determine their position in relation to a wound. She’s passionate about bringing science to the public through effective scientific communication and meaningful technological advances.
Marilene Pavan, Ph.D.
LinkedIn
Marilene is a High-Throughput Synthetic Biology Manager at LanzaTech Inc., a carbon recycling technology company, specialized in converting waste carbon oxides into biofuels and chemicals. She is a Biologist with 15+ years of experience in the fields of synthetic biology, metabolic engineering, and biomanufacturing, with previous experience working for chemical industries like Braskem S/A and leading biotech companies as Monsanto S/A, She moved to the US in 2016 to work as Research Fellow at Boston University, later joining Lanzatech in 2019. Her expertise also includes partnerships (prospection and management); people management and mentorship; fundraising; business development; grant, patent, and scientific article writing; project evaluation and management; budget management; scientific consulting; and conference planning and speaking. She holds a master’s degree in Molecular Biology and is also specialized in Strategic Management of Technological Innovation. She is currently a Ph.D. Candidate in the Bioenergy Program of the University of Campinas, UNICAMP – Brazil.
This is an invitation-only event.
Register here
The second EBRC Global Forum for Engineering Biology: Review of Synthetic Biology/Bioeconomy National Strategies (EBRC Global Forum 2.0) will be held on the 20th and 21st of February 2023 in Singapore in partnership with the Singapore Consortium for Synthetic Biology (SINERGY). The Forum will bring together a group of global leaders for an international summit focused on national synthetic biology roadmaps and bioeconomy strategies. Our goal is to facilitate presentations and discussions among leading representatives in the field in a relaxed, not-for-attribution forum.
The two-day agenda will include:
Participants are expected to cover their own travel and accommodation expenses. We will facilitate room blocks and/or make recommendations for accommodation, but we will not be covering the costs. We have some limited ability, on a case-by-case basis, to fund travel for those who could not otherwise participate without travel funding assistance.
We are pleased to announce our new conference on synthetic biology. This conference will present how technologies from synthetic biology are delivering innovations across clinical health applications and leading towards improved global health.
The meeting will bring together researchers working on synthetic biology, biotechnology, genomics and medical sciences, along with industry members from pharma and biotech companies, and investors and funders in this growing research area. It will address how the technologies coming out of synthetic biology impact both advanced healthcare in developed countries (e.g. personalised medicines, T-cell therapies) and global wide-impact, such as very low-cost diagnostics and self-replicating living therapies. In addition, the conference aims to provide a reflection on where resources and work are succeeding and where more effort needs to be placed to ensure equitable global outcomes.
We aim to organise this meeting as a hybrid conference – with on-site or virtual attendance. If you would like to be part of these discussions – consider submitting an abstract by 17 January 2023 and register by 14 February (in-person) or 6 March (virtual) 2023.
To promote more inclusive scientific discussions with international colleagues at our conferences, virtual delegates based in Lower and Middle-Income Countries can register for free.
GOGEC, a virtual conference, allows students to present their work and meet other synthetic biology students around the world without having to worry about registration fees. Projects can include any sort of synthetic biology work including engineering organisms, purely computational or software work, or building non-biological devices with biological applications. You can find more information and register here.
